Neupro 8mg/24h transdermal patches (Rotigotine PATCH) 8mg

Neupro 8mg/24h transdermal patches contain rotigotine, a dopamine agonist used for managing Parkinson’s disease and restless legs syndrome symptoms. These patches provide steady medication release over 24 hours. Store between 2-8°C to maintain potency.

Strength

8mg

Pack Size

Pack of 28

Storage

2-8°

Manufacturer / TM Owner

UCB Pharma

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Rotigotine transdermal patches are commonly used to help manage symptoms of Parkinson’s disease, including tremors, stiffness, and movement difficulties. They are also prescribed for moderate to severe restless legs syndrome to reduce nighttime leg discomfort. These patches deliver the medication gradually through the skin.

Side Effects

Users may experience improved mobility and reduced tremors when using rotigotine patches as part of their treatment plan. Some individuals report better sleep quality, particularly those managing restless legs syndrome symptoms. Effects can vary based on individual response and condition being treated.

Precautions & Warnings

Keep patches in their original sealed pouch until use to protect from moisture and light. Apply to clean, dry, and intact skin on the abdomen, thigh, hip, flank, shoulder, or upper arm, rotating sites daily. Avoid exposing the patch area to heat sources like heating pads or saunas.

Avoid Interactions

Alcohol may increase the sedative effects of rotigotine, so caution is advised when consuming alcoholic beverages. Combining with other central nervous system depressants could enhance drowsiness. Always inform healthcare providers about all medications being taken to assess potential interactions.

Frequently Asked Questions

Rotigotine is used to treat symptoms of Parkinson’s disease and moderate to severe restless legs syndrome.

The patches deliver rotigotine through the skin, providing a steady dose over 24 hours.

Consult a healthcare provider before using any medication during pregnancy.

Store patches between 2-8°C in their original sealed pouch until use.

Common effects may include drowsiness, nausea, or skin reactions at the application site.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.